276 related articles for article (PubMed ID: 32145655)
1. A real-world assessment of procalcitonin combined with antimicrobial stewardship in a community ICU.
Langford BJ; Beriault D; Schwartz KL; Seah J; Pasic MD; Cirone R; Chan A; Downing M
J Crit Care; 2020 Jun; 57():130-133. PubMed ID: 32145655
[TBL] [Abstract][Full Text] [Related]
2. Procalcitonin-guided antibiotic therapy for suspected and confirmed sepsis of patients in a surgical trauma ICU: a prospective, two period cross-over, interventional study.
Chomba RN; Moeng MS; Lowman W
S Afr J Surg; 2020 Sep; 5(3):143-149. PubMed ID: 33231007
[TBL] [Abstract][Full Text] [Related]
3. Stop Antibiotics on guidance of Procalcitonin Study (SAPS): a randomised prospective multicenter investigator-initiated trial to analyse whether daily measurements of procalcitonin versus a standard-of-care approach can safely shorten antibiotic duration in intensive care unit patients--calculated sample size: 1816 patients.
Assink-de Jong E; de Lange DW; van Oers JA; Nijsten MW; Twisk JW; Beishuizen A
BMC Infect Dis; 2013 Apr; 13():178. PubMed ID: 23590389
[TBL] [Abstract][Full Text] [Related]
4. Analysis to determine cost-effectiveness of procalcitonin-guided antibiotic use in adult patients with suspected bacterial infection and sepsis.
Collins CD; Brockhaus K; Sim T; Suneja A; Malani AN
Am J Health Syst Pharm; 2019 Aug; 76(16):1219-1225. PubMed ID: 31369118
[TBL] [Abstract][Full Text] [Related]
5. Procalcitonin algorithm to guide initial antibiotic therapy in acute exacerbations of COPD admitted to the ICU: a randomized multicenter study.
Daubin C; Valette X; Thiollière F; Mira JP; Hazera P; Annane D; Labbe V; Floccard B; Fournel F; Terzi N; Du Cheyron D; Parienti JJ;
Intensive Care Med; 2018 Apr; 44(4):428-437. PubMed ID: 29663044
[TBL] [Abstract][Full Text] [Related]
6. Association of kidney function with effectiveness of procalcitonin-guided antibiotic treatment: a patient-level meta-analysis from randomized controlled trials.
Heilmann E; Gregoriano C; Wirz Y; Luyt CE; Wolff M; Chastre J; Tubach F; Christ-Crain M; Bouadma L; Annane D; Damas P; Kristoffersen KB; Oliveira CF; Stolz D; Tamm M; de Jong E; Reinhart K; Shehabi Y; Verduri A; Nobre V; Nijsten M; deLange DW; van Oers JAH; Beishuizen A; Girbes ARJ; Mueller B; Schuetz P
Clin Chem Lab Med; 2020 Sep; 59(2):441-453. PubMed ID: 32986609
[TBL] [Abstract][Full Text] [Related]
7. Ineffectiveness of procalcitonin-guided antibiotic therapy in severely critically ill patients: A meta-analysis.
Peng F; Chang W; Xie JF; Sun Q; Qiu HB; Yang Y
Int J Infect Dis; 2019 Aug; 85():158-166. PubMed ID: 31229612
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial.
de Jong E; van Oers JA; Beishuizen A; Vos P; Vermeijden WJ; Haas LE; Loef BG; Dormans T; van Melsen GC; Kluiters YC; Kemperman H; van den Elsen MJ; Schouten JA; Streefkerk JO; Krabbe HG; Kieft H; Kluge GH; van Dam VC; van Pelt J; Bormans L; Otten MB; Reidinga AC; Endeman H; Twisk JW; van de Garde EMW; de Smet AMGA; Kesecioglu J; Girbes AR; Nijsten MW; de Lange DW
Lancet Infect Dis; 2016 Jul; 16(7):819-827. PubMed ID: 26947523
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of procalcitonin-guided antibiotic therapy to shorten treatment duration in critically-ill patients with bloodstream infections: a systematic review and meta-analysis.
Robati Anaraki M; Nouri-Vaskeh M; Abdoli Oskouie S
Infez Med; 2020 Mar; 28(1):37-46. PubMed ID: 32172259
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of procalcitonin testing to guide antibiotic treatment duration in critically ill patients: results from a randomised controlled multicentre trial in the Netherlands.
Kip MMA; van Oers JA; Shajiei A; Beishuizen A; Berghuis AMS; Girbes AR; de Jong E; de Lange DW; Nijsten MWN; IJzerman MJ; Koffijberg H; Kusters R
Crit Care; 2018 Nov; 22(1):293. PubMed ID: 30424796
[TBL] [Abstract][Full Text] [Related]
11. Procalcitonin to guide antibiotic decision making.
Branche A; Neeser O; Mueller B; Schuetz P
Curr Opin Infect Dis; 2019 Apr; 32(2):130-135. PubMed ID: 30648993
[TBL] [Abstract][Full Text] [Related]
12. Procalcitonin testing to guide antibiotic therapy for the treatment of sepsis in intensive care settings and for suspected bacterial infection in emergency department settings: a systematic review and cost-effectiveness analysis.
Westwood M; Ramaekers B; Whiting P; Tomini F; Joore M; Armstrong N; Ryder S; Stirk L; Severens J; Kleijnen J
Health Technol Assess; 2015 Nov; 19(96):v-xxv, 1-236. PubMed ID: 26569153
[TBL] [Abstract][Full Text] [Related]
13. Antibiotic stewardship: Early discontinuation of antibiotics based on procalcitonin level in COVID-19 pneumonia.
Roy A; Powers HR; Craver EC; Nazareno MD; Yarrarapu SNS; Sanghavi DK
J Clin Pharm Ther; 2022 Feb; 47(2):243-247. PubMed ID: 34766357
[TBL] [Abstract][Full Text] [Related]
14. Procalcitonin-guided Antibiotic Treatment in Patients With Positive Blood Cultures: A Patient-level Meta-analysis of Randomized Trials.
Meier MA; Branche A; Neeser OL; Wirz Y; Haubitz S; Bouadma L; Wolff M; Luyt CE; Chastre J; Tubach F; Christ-Crain M; Corti C; Jensen JS; Deliberato RO; Kristoffersen KB; Damas P; Nobre V; Oliveira CF; Shehabi Y; Stolz D; Tamm M; Mueller B; Schuetz P
Clin Infect Dis; 2019 Jul; 69(3):388-396. PubMed ID: 30358811
[TBL] [Abstract][Full Text] [Related]
15. How to: implement procalcitonin testing in my practice.
Neeser O; Branche A; Mueller B; Schuetz P
Clin Microbiol Infect; 2019 Oct; 25(10):1226-1230. PubMed ID: 30616016
[TBL] [Abstract][Full Text] [Related]
16. Procalcitonin for sepsis management: Implementation within an antimicrobial stewardship program.
Fugit RV; McCoury JB; Bessesen MT
Am J Health Syst Pharm; 2023 May; 80(Suppl 2):S49-S54. PubMed ID: 36371732
[TBL] [Abstract][Full Text] [Related]
17. The use of procalcitonin for the management of sepsis in Internal Medicine wards: current evidence.
Tosoni A; Paratore M; Piscitelli P; Addolorato G; De Cosmo S; Mirijello A;
Panminerva Med; 2020 Mar; 62(1):54-62. PubMed ID: 31729202
[TBL] [Abstract][Full Text] [Related]
18. Procalcitonin-Guided Treatment on Duration of Antibiotic Therapy and Cost in Septic Patients (PRODA): a Multi-Center Randomized Controlled Trial.
Jeon K; Suh JK; Jang EJ; Cho S; Ryu HG; Na S; Hong SB; Lee HJ; Kim JY; Lee SM
J Korean Med Sci; 2019 Apr; 34(14):e110. PubMed ID: 30977312
[TBL] [Abstract][Full Text] [Related]
19. Impact of Procalcitonin Guidance with an Educational Program on Management of Adults Hospitalized with Pneumonia.
Walsh TL; DiSilvio BE; Hammer C; Beg M; Vishwanathan S; Speredelozzi D; Moffa MA; Hu K; Abdulmassih R; Makadia JT; Sandhu R; Naddour M; Chan-Tompkins NH; Trienski TL; Watson C; Obringer TJ; Kuzyck J; Bremmer DN
Am J Med; 2018 Feb; 131(2):201.e1-201.e8. PubMed ID: 28947168
[TBL] [Abstract][Full Text] [Related]
20. Comparison of procalcitonin testing to a targeted audit-and-feedback strategy on prescribed durations of therapy for community-acquired pneumonia.
Clark LT; Beuschel TS; Buss PM; Jameson AP; Dumkow LE
Diagn Microbiol Infect Dis; 2021 Jan; 99(1):115202. PubMed ID: 33007583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
